Copyright
©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1804-1816
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1804
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1804
Variables | Weighted, n | Weighted, % (95%Cl) |
Total, n | 18031 | |
Sex | ||
Female | 6903 | 38.27 (36.59–39.9) |
Male | 11123 | 61.69 (59.9–63.4) |
Age (y), mean (SD) | 62.19 ± 34.36 | |
Age groups (yr) | ||
< 18 | 158 | 0.88 (0.54–1.20) |
18-44 | 2046 | 11.37 (10.2–12.5) |
45-64 | 7007 | 38.90 (37.15–40.6) |
65-84 | 7933 | 43.93 (42.2–45.7) |
85+ | 887 | 4.91 (4.15–5.69) |
Race/Ethnicity | ||
White | 15850 | 87.87 (86.6–89.2) |
Black | 315 | 1.76 (1.30–2.19) |
Hispanic | 545 | 3.01 (2.42–3.62) |
Asian or Pacific Islander | 105 | 0.58 (0.33–0.83) |
Native American | 30 | 0.17 (0.03–0.30) |
Other | 1186 | 6.60 (5.52–7.63) |
Comorbidities | ||
Coronary artery disease | 3357 | 18.61 (17.24–20.0) |
Cardiomyopathy | 900 | 4.99 (4.19–5.79) |
Arrythmias | 4250 | 23.57 (22.1–25.1) |
Heart failure | 2848 | 15.79 (14.5–17.1) |
Liver cancer | 209 | 1.16 (0.78–1.53) |
HIV | 35 | 0.19 (0.05–0.34) |
Alpha1-antitrypsin deficiency | 55 | 0.31 (0.11–0.49) |
Disorders of porphyrin metabolism | 105 | 0.58 (0.30–0.86) |
Hepatomegaly | 123 | 0.68 (0.38–0.98) |
Splenomegaly | 169 | 0.93 (0.56–1.32) |
Hypertension | 7892 | 43.76 (42.0–45.5) |
Diabetes mellitus with chronic complications | 2323 | 12.88 (11.7–14.1) |
Diabetes mellitus without chronic complications | 2485 | 13.78 (12.6–15.0) |
Lipid metabolism disorders | 6781 | 37.60 (35.9–39.3) |
Thyroid disorders | 3285 | 18.21 (16.9–15.6) |
Pancreatitis | 484 | 2.69 (2.13–3.23) |
Pituitary disorders | 259 | 1.43 (0.99–1.87) |
Obesity | 2971 | 16.48 (15.1–17.9) |
Depression | 2673 | 14.82 (13.5–16.1) |
Symptoms | ||
Musculoskeletal pain | 1011 | 5.61 (4.79–6.42) |
Malaise and fatigue | 557 | 3.09 (2.49–3.68) |
Arthropathy | 384 | 2.13 (1.65–2.61) |
Weight Loss | 219 | 1.22 (0.81–1.61) |
Loss of appetite | 87 | 0.49 (0.26–0.70) |
Hypogonadism | 193 | 1.07 (0.66–1.49) |
Erectile dysfunction | 140 | 0.78 (0.45–1.10) |
jaundice | 184 | 1.02 (0.67–1.38) |
Disorientation | 374 | 2.07 (1.61–2.54) |
Family history | ||
Family history of diseases of the circulatory system | 1109 | 6.15 (5.26–7.04) |
Family history of diabetes mellitus | 500 | 2.77 (2.17–3.37) |
Family history of malignant neoplasms | 814 | 4.51 (3.77–5.25) |
Substance use | ||
Smoking | 7577 | 42.02 (40.2–43.8) |
Alcohol | 1536 | 8.52 (7.49–9.54) |
Cannabis use | 219 | 1.22 (0.83–1.60) |
Opioids | 315 | 1.74 (1.29–2.20) |
- Citation: Haider MB, Al Sbihi A, Chaudhary AJ, Haider SM, Edhi AI. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study. World J Hepatol 2022; 14(9): 1804-1816
- URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1804.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1804